Selected Papers from Immunotherapies for Infectious Diseases Conference (I4ID) (Lyon 2017)
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (1 June 2018) | Viewed by 127
Special Issue Editors
Interests: technological Innovations applied to vaccines and diagnostics in the field of infectious diseases
Special Issue Information
Dear Colleagues,
The 2017 Immunotherapies for Infectious Diseases congress (I4ID2017), organized by the Technical Research Institute in Microbiology, BIOASTER and MabDesign, a French non-profit association supporting the economic development of the French industrial sector in the field of immunotherapy, will be held in Lyon, France, 11–12 December, 2017. The main purpose of this two-day congress is to promote the use of immunotherapies for the prevention and treatment of infectious diseases, while fostering interactions between pharmaceutical industries, research labs or academic facilities, service providers, and technology developers. To this end, the scientific committee has set-up an exciting program, including keynote lectures, pitch-talks on new creative projects, and industrial presentations from big pharmaceutical companies, together with several opportunities for networking and dedicated time for business partnering.
Basically, the conferences will focus on immunotherapy against viral infections, immunotherapy as alternative treatment to antibiotics, immunotherapy against emergent or re-emergent and bioterrorism agents, next-generation immunotherapy against infectious diseases, and a cross-talk about challenges for access to immunotherapies in emerging countries.
Dr. Patrick Lécine
Dr. Guillaume Desoubeaux
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Immunotherapies
- Infectious diseases
- Antimicrobial resistance
- Antiviral
